MKGAY - Pfizer/Merck Bavencio shows positive effect in bladder cancer study September, 18 2020 05:16 AM Merck KGaA ADR Pfizer (NYSE:PFE) and Merck KGaA (OTCPK:MKGAY) company EMD Serono announce the publication of detailed results from the Phase III JAVELIN Bladder 100 study at the European Society for Medical Oncology (ESMO) Virtual Congress 2020.More news on: Pfizer Inc., Merck KGaA ADR, MERCK Kommanditgesellschaft auf Aktien, Healthcare stocks news, Read more ...